title: Why 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis?
authors: Laura
authors: L
authors: Di Renzo
authors: Rosita
authors: R
authors: Saraceno
authors: Caterina
authors: C
authors: Schipani
authors: Sergio
authors: S
authors: Chimenti
authors: Antonino
authors: A
authors: De Lorenzo
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000191:economics; D015535:Arthritis, Psoriatic / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D001823:Body Composition; D016022:Case-Control Studies; D006801:Humans; D000069285:Infliximab; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab